Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Terns Pharmaceuticals Inc (TERN)

Terns Pharmaceuticals Inc (TERN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 5,491,032
  • Shares Outstanding, K 103,761
  • Annual Sales, $ 0 K
  • Annual Income, $ -88,850 K
  • EBIT $ -108 M
  • EBITDA $ -108 M
  • 60-Month Beta -0.31
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 16.38

Options Overview Details

View History
  • Implied Volatility 16.07% (+0.58%)
  • Historical Volatility 36.85%
  • IV Percentile 1%
  • IV Rank 0.10%
  • IV High 573.79% on 10/24/25
  • IV Low 15.49% on 03/26/26
  • Expected Move (DTE 20) 1.87 (3.53%)
  • Put/Call Vol Ratio 1.97
  • Today's Volume 12,068
  • Volume Avg (30-Day) 12,853
  • Put/Call OI Ratio 0.38
  • Today's Open Interest 167,838
  • Open Int (30-Day) 50,953
  • Expected Range 51.05 to 54.79

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 11 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/25
See More
  • Average Estimate -0.29
  • Number of Estimates 6
  • High Estimate -0.28
  • Low Estimate -0.33
  • Prior Year -0.24
  • Growth Rate Est. (year over year) -20.83%

Price Performance

See More
Period Period Low Period High Performance
1-Month
38.82 +36.32%
on 03/03/26
53.19 -0.51%
on 03/26/26
+10.80 (+25.64%)
since 02/27/26
3-Month
33.43 +58.30%
on 01/12/26
53.19 -0.51%
on 03/26/26
+11.40 (+27.46%)
since 12/26/25
52-Week
1.87 +2,737.53%
on 04/07/25
53.19 -0.51%
on 03/26/26
+49.80 (+1,596.15%)
since 03/27/25

Most Recent Stories

More News
Are TERN, CRBG, EQH Obtaining Fair Deals for their Shareholders?

Insiders may stand to receive substantial financial benefits not available to ordinary shareholders.

TERN : 52.92 (-0.47%)
CRBG : 22.30 (-8.64%)
EQH : 35.34 (-8.28%)
Terns Pharmaceuticals Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Terns Pharmaceuticals, Inc. - TERN

Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti , LLC (“KSF”) are investigating the proposed sale of Terns Pharmaceuticals...

MRK : 119.63 (+0.59%)
TERN : 52.92 (-0.47%)
Merck Acquisition Overshadows Terns Pharmaceuticals Earnings as Biotech Reports Tomorrow

Barchart Research What to Expect from TERN Earnings TERN Generated March 25, 2026 Current Price $52.86 EPS Estimate $-0.29 Consensus Rating Strong Buy Average Move 4.93% Merck Acquisition Overshadows Terns...

TERN : 52.92 (-0.47%)
Stocks Finish Higher on US Push to End Iran War

The S&P 500 Index ($SPX ) (SPY ) on Wednesday closed up +0.54%, the Dow Jones Industrial Average ($DOWI ) (DIA ) closed up +0.66%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.67%. June E-mini...

SNDK : 615.83 (+2.10%)
RKLB : 60.93 (-7.60%)
TERN : 52.92 (-0.47%)
TXN : 190.33 (-1.59%)
$IUXX : 23,132.77 (-1.93%)
ZNM26 : 110-050s (-0.01%)
KBH : 50.91 (-1.93%)
ESM26 : 6,412.25s (-1.73%)
QCOM : 127.11 (-2.63%)
STX : 380.07 (+0.34%)
WDC : 275.34 (+0.73%)
AMD : 201.99 (-0.87%)
$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Terns Pharmaceuticals, Inc. (NASDAQ: TERN)

NEW YORK , March 25, 2026 /PRNewswire/ -- Class Action Attorney  Juan Monteverde with Monteverde & Associates PC (the "M&A Class Action Firm"), has recovered millions of dollars for...

TERN : 52.92 (-0.47%)
Stocks Climb on Hopes of US-Iran Diplomacy

The S&P 500 Index ($SPX ) (SPY ) today is up +0.83%, the Dow Jones Industrial Average ($DOWI ) (DIA ) is up +0.86%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +1.06%. June E-mini S&P futures (ESM26...

ALK : 36.16 (-7.16%)
MSTR : 126.03 (-5.19%)
UAL : 88.44 (-4.59%)
SNDK : 615.83 (+2.10%)
GLXY : 18.00 (-8.21%)
RKLB : 60.93 (-7.60%)
TERN : 52.92 (-0.47%)
TXN : 190.33 (-1.59%)
$IUXX : 23,132.77 (-1.93%)
COIN : 161.14 (-7.06%)
ZNM26 : 110-050s (-0.01%)
KBH : 50.91 (-1.93%)
Stocks Rally on US Peace Plan to End Iran War

The S&P 500 Index ($SPX ) (SPY ) today is up +0.62%, the Dow Jones Industrial Average ($DOWI ) (DIA ) is up +0.67%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.75%. June E-mini S&P futures (ESM26...

ALK : 36.16 (-7.16%)
MSTR : 126.03 (-5.19%)
UAL : 88.44 (-4.59%)
SNDK : 615.83 (+2.10%)
GLXY : 18.00 (-8.21%)
TERN : 52.92 (-0.47%)
TXN : 190.33 (-1.59%)
$IUXX : 23,132.77 (-1.93%)
COIN : 161.14 (-7.06%)
ZNM26 : 110-050s (-0.01%)
KBH : 50.91 (-1.93%)
ESM26 : 6,412.25s (-1.73%)
Shareholder Alert: The Ademi Firm investigates whether Terns Pharmaceuticals Inc. is obtaining a Fair Price for Public Shareholders

MILWAUKEE , March 25, 2026 /PRNewswire/ -- Ademi LLP is investigating Terns (NASDAQ: TERN) for possible breaches of fiduciary duty and other violations of law in its recently announced transaction...

TERN : 52.92 (-0.47%)
TERN Stock Alert: Halper Sadeh LLC is Investigating Whether Terns Pharmaceuticals, Inc. is Obtaining a Fair Price for its Shareholders

Insiders may stand to receive substantial financial benefits not available to ordinary shareholders. The proposed transaction may contain terms that...

TERN : 52.92 (-0.47%)
Merck to Acquire Terns Pharmaceuticals, Inc., Expanding Its Hematology Pipeline With TERN-701, a Novel Candidate for Chronic Myeloid Leukemia (CML)

Terns’ lead candidate TERN-701 is an investigational oral  allosteric BCR::ABL1 tyrosine kinase inhibitor c urrently in Phase 1/2 development for certain patients with CML Merck to hold investor...

MRK : 119.63 (+0.59%)
TERN : 52.92 (-0.47%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

Relative Strength is above 70%. The market is in overbought territory. Watch for a potential trend reversal.

See More Share

Business Summary

Terns Pharmaceuticals Inc. is a clinical-stage biopharmaceutical company. It engages in development of small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis and other chronic liver diseases. Terns Pharmaceuticals Inc. is based in FOSTER CITY,...

See More

Key Turning Points

3rd Resistance Point 53.20
2nd Resistance Point 53.14
1st Resistance Point 53.03
Last Price 52.92
1st Support Level 52.86
2nd Support Level 52.80
3rd Support Level 52.69

See More

52-Week High 53.19
Last Price 52.92
Fibonacci 61.8% 33.58
Fibonacci 50% 27.53
Fibonacci 38.2% 21.47
52-Week Low 1.87

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.